Photo for illustrative purposes only. Photo by National Cancer Institute / Unsplash
Subscribe to our Telegram channel to get a daily dose of business and lifestyle news […]
Celltrion announces positive top-line results from global Phase III trial of regdanvimab (CT-P59), an anti-COVID-19 monoclonal antibody treatmentanne2021-06-15T11:15:49+08:00